A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

“GLP-1 RAs’ distinct and unique mechanism of enhancing insulin release in response to glucose, increasing satiety, and slowing gastric emptying can be attributed to the previously mentioned ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found ... for cravings—the same mechanism that could contribute to weight ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

Amanda Bonello – who lives in Iowa – decided to take action. “I haven't seen any ... more than 15,000 clients with compounded GLP-1. “Compounded products are very clean, very simple ...

NEW YORK — Popular GLP-1 medications approved for weight loss ... After waiting over eight months for a refund from a medical clinic, an ABC Action News viewer reached out to consumer ...

Novo Nordisk's experimental obesity drug, amycretin, displayed impressive results, causing a 22% weight loss in participants over 36 weeks. The news boosted Novo’s shares and highlights its potential ...